# Mgic Investment Corp: financial statements, quarterly

MTG · NYSE · CIK 876437 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtg.md) · [Financials](/companies/mtg/financials.md) · [Filings](/companies/mtg/filings.md) · [Insiders](/companies/mtg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [297](/filings/0000876437-24-000111.md) | [284 d](/filings/0000876437-26-000010.md) | [294](/filings/0000876437-25-000074.md) | [305](/filings/0000876437-25-000115.md) | [307](/filings/0000876437-25-000127.md) | [301 d](/filings/0000876437-26-000010.md) | [306](/filings/0000876437-26-000022.md) | [304](/filings/0000876437-26-000028.md) | [305](/filings/0000876437-25-000127.md) | [299 d](/filings/0000876437-26-000010.md) | [297](/filings/0000876437-26-000022.md) | [295](/filings/0000876437-26-000028.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [51.6](/filings/0000876437-24-000111.md) | [45.3 d](/filings/0000876437-26-000010.md) | [45.8](/filings/0000876437-25-000074.md) | [55.6](/filings/0000876437-25-000115.md) | [54.3](/filings/0000876437-25-000127.md) | [50.0 d](/filings/0000876437-26-000010.md) | [49.2](/filings/0000876437-26-000022.md) | [53.6](/filings/0000876437-26-000028.md) | [44.0](/filings/0000876437-25-000127.md) | [43.4 d](/filings/0000876437-26-000010.md) | [41.5](/filings/0000876437-26-000022.md) | [47.8](/filings/0000876437-26-000028.md) |
| Net income | $m | [183](/filings/0000876437-24-000111.md) | [185 d](/filings/0000876437-26-000010.md) | [174](/filings/0000876437-25-000074.md) | [204](/filings/0000876437-25-000115.md) | [200](/filings/0000876437-25-000127.md) | [185 d](/filings/0000876437-26-000010.md) | [185](/filings/0000876437-26-000022.md) | [192](/filings/0000876437-26-000028.md) | [191](/filings/0000876437-25-000127.md) | [169 d](/filings/0000876437-26-000010.md) | [165](/filings/0000876437-26-000022.md) | [182](/filings/0000876437-26-000028.md) |
| Diluted EPS | $ per share | [0.64](/filings/0000876437-24-000111.md) | not reported | [0.64](/filings/0000876437-25-000074.md) | [0.77](/filings/0000876437-25-000115.md) | [0.77](/filings/0000876437-25-000127.md) | not reported | [0.75](/filings/0000876437-26-000022.md) | [0.81](/filings/0000876437-26-000028.md) | [0.83](/filings/0000876437-25-000127.md) | not reported | [0.76](/filings/0000876437-26-000022.md) | [0.86](/filings/0000876437-26-000028.md) |
| Basic EPS | $ per share | [0.65](/filings/0000876437-24-000111.md) | not reported | [0.64](/filings/0000876437-25-000074.md) | [0.77](/filings/0000876437-25-000115.md) | [0.77](/filings/0000876437-25-000127.md) | not reported | [0.76](/filings/0000876437-26-000022.md) | [0.81](/filings/0000876437-26-000028.md) | [0.83](/filings/0000876437-25-000127.md) | not reported | [0.76](/filings/0000876437-26-000022.md) | [0.87](/filings/0000876437-26-000028.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [267](/filings/0000876437-23-000073.md) | [364](/filings/0000876437-25-000036.md) | [431](/filings/0000876437-24-000064.md) | [282](/filings/0000876437-24-000081.md) | [289](/filings/0000876437-24-000111.md) | [229](/filings/0000876437-26-000010.md) | [207](/filings/0000876437-25-000074.md) | [295](/filings/0000876437-25-000115.md) | [267](/filings/0000876437-25-000127.md) | [369](/filings/0000876437-26-000028.md) | [235](/filings/0000876437-26-000022.md) | [207](/filings/0000876437-26-000028.md) |
| Total assets | $m | [6,332](/filings/0000876437-23-000073.md) | [6,538](/filings/0000876437-25-000036.md) | [6,535](/filings/0000876437-24-000064.md) | [6,524](/filings/0000876437-24-000081.md) | [6,678](/filings/0000876437-24-000111.md) | [6,547](/filings/0000876437-26-000010.md) | [6,535](/filings/0000876437-25-000074.md) | [6,542](/filings/0000876437-25-000115.md) | [6,626](/filings/0000876437-25-000127.md) | [6,639](/filings/0000876437-26-000028.md) | [6,417](/filings/0000876437-26-000022.md) | [6,527](/filings/0000876437-26-000028.md) |
| Total liabilities | $m | [1,477](/filings/0000876437-23-000073.md) | [1,466](/filings/0000876437-25-000036.md) | [1,433](/filings/0000876437-24-000064.md) | [1,407](/filings/0000876437-24-000081.md) | [1,384](/filings/0000876437-24-000111.md) | [1,375](/filings/0000876437-26-000010.md) | [1,395](/filings/0000876437-25-000074.md) | [1,387](/filings/0000876437-25-000115.md) | [1,453](/filings/0000876437-25-000127.md) | [1,492](/filings/0000876437-26-000028.md) | [1,379](/filings/0000876437-26-000022.md) | [1,514](/filings/0000876437-26-000028.md) |
| Long-term debt | $m | [643](/filings/0000876437-23-000073.md) | [643](/filings/0000876437-24-000024.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [4,855](/filings/0000876437-24-000111.md) | [5,072](/filings/0000876437-26-000010.md) | [5,102](/filings/0000876437-25-000074.md) | [5,117](/filings/0000876437-25-000115.md) | [5,294](/filings/0000876437-25-000127.md) | [5,172](/filings/0000876437-26-000010.md) | [5,140](/filings/0000876437-26-000022.md) | [5,155](/filings/0000876437-26-000028.md) | [5,173](/filings/0000876437-25-000127.md) | [5,148](/filings/0000876437-26-000028.md) | [5,037](/filings/0000876437-26-000022.md) | [5,013](/filings/0000876437-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [170 d](/filings/0000876437-24-000111.md) | [186 d](/filings/0000876437-26-000010.md) | [191](/filings/0000876437-25-000074.md) | [169 d](/filings/0000876437-25-000115.md) | [183 d](/filings/0000876437-25-000127.md) | [182 d](/filings/0000876437-26-000010.md) | [224](/filings/0000876437-26-000022.md) | [183 d](/filings/0000876437-26-000028.md) | [215 d](/filings/0000876437-25-000127.md) | [231 d](/filings/0000876437-26-000010.md) | [76.9](/filings/0000876437-26-000022.md) | [185 d](/filings/0000876437-26-000028.md) |
| Capital expenditure | $m | [0.8 d](/filings/0000876437-24-000111.md) | [0.5 d](/filings/0000876437-26-000010.md) | [0.0](/filings/0000876437-25-000074.md) | [0.3 d](/filings/0000876437-25-000115.md) | [0.4 d](/filings/0000876437-25-000127.md) | [0.5 d](/filings/0000876437-26-000010.md) | [0.1](/filings/0000876437-26-000022.md) | [0.0 d](/filings/0000876437-26-000028.md) | [0.3 d](/filings/0000876437-25-000127.md) | [0.6 d](/filings/0000876437-26-000010.md) | [0.2](/filings/0000876437-26-000022.md) | [0.5 d](/filings/0000876437-26-000028.md) |
| Dividends paid | $m | [32.5 d](/filings/0000876437-24-000111.md) | [31.8 d](/filings/0000876437-26-000010.md) | [33.4](/filings/0000876437-25-000074.md) | [30.6 d](/filings/0000876437-25-000115.md) | [33.7 d](/filings/0000876437-25-000127.md) | [32.9 d](/filings/0000876437-26-000010.md) | [33.9](/filings/0000876437-26-000022.md) | [30.8 d](/filings/0000876437-26-000028.md) | [34.4 d](/filings/0000876437-25-000127.md) | [33.4 d](/filings/0000876437-26-000010.md) | [35.2](/filings/0000876437-26-000022.md) | [31.6 d](/filings/0000876437-26-000028.md) |
| Share repurchases | $m | [66.5 d](/filings/0000876437-24-000111.md) | [120 d](/filings/0000876437-26-000010.md) | [95.2](/filings/0000876437-25-000074.md) | [156 d](/filings/0000876437-25-000115.md) | [124 d](/filings/0000876437-25-000127.md) | [195 d](/filings/0000876437-26-000010.md) | [225](/filings/0000876437-26-000022.md) | [186 d](/filings/0000876437-26-000028.md) | [188 d](/filings/0000876437-25-000127.md) | [189 d](/filings/0000876437-26-000010.md) | [192](/filings/0000876437-26-000022.md) | [185 d](/filings/0000876437-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [307](/filings/0000876437-23-000073.md) | [295](/filings/0000876437-24-000064.md) | [290](/filings/0000876437-24-000081.md) | [286](/filings/0000876437-24-000111.md) | [273](/filings/0000876437-25-000074.md) | [267](/filings/0000876437-25-000115.md) | [261](/filings/0000876437-25-000127.md) | [246](/filings/0000876437-26-000022.md) | [238](/filings/0000876437-26-000028.md) | [231](/filings/0000876437-25-000127.md) | [218](/filings/0000876437-26-000022.md) | [211](/filings/0000876437-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 205,124,840 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0000876437-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.